Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Concizumab

EU orphan designation number: EU/3/17/1940   
Active ingredient: Concizumab
Indication: Treatment of haemophilia B
Sponsor: Novo Nordisk A/S
Novo Alle 1, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/11/2017 Orphan designation EMA/OD/116/17 (2017)7563 of 8/11/2017